Eagle Pharmaceuticals Inc (EGRX)

概要ニュース株価時系列オプションチェーン Financials ディスカッション予測

Eagle Pharmaceuticals Inc (EGRX) 最新ニュース

Eagle Pharmaceuticals Inc (EGRX)

Eagle Pharmaceuticals Inc (EGRX) 最新ニュース

EGRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Eagle Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated by Analysts at StockNews.com - Defense World

Eagle Pharmaceuticals, Inc. Enters Third Amended and Restated Credit Agreement - Marketscreener.com

StockNews.com Begins Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX) - Defense World

Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated at StockNews.com - Defense World

Jane Street Group LLC Makes New Investment in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09% - MSN

Antiemetics Drugs Market Size & Share Report, 2024 – 2032 - Global Market Insights

Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by StockNews.com - Defense World

Last Week's Biggest Stock Movers: Eagle, Noodles & Co. - AOL

Eagle Pharmaceuticals Enters Into Settlement Agreement With Dr. Reddy's Laboratories on Leukemia Drug - Marketscreener.com

Eagle Pharmaceuticals : to Present at Jefferies Virtual Healthcare Conference 2021 - Marketscreener.com

Eagle Pharmaceuticals Amends Rights Agreement with Equiniti Trust Company - Defense World

Eagle Pharmaceuticals amends rights agreement - Investing.com

Eagle Pharmaceuticals amends rights agreement By Investing.com - Investing.com Nigeria

Eagle Pharmaceuticals Dismisses Ernst & Young LLP as Independent Registered Public Accounting Firm - Defense World

Eagle Pharmaceuticals switches to BDO after Ernst & Young dismissal - Investing.com

Eagle Pharmaceuticals switches to BDO after Ernst & Young dismissal By Investing.com - Investing.com UK

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceutica - GuruFocus.com

Eagle Pharma Founder Sues Company to Recoup Cost of SEC Investigation - Law.com

Ex-Pharma CEO Demands Legal Fees For SEC Probe - Law360

Eagle Pharmaceuticals names Christopher Krawtschuk as CFO - MSN

Eagle Pharmaceuticals to Delist from Nasdaq By Investing.com - Investing.com Australia

Eagle Pharmaceuticals, Inc. Announces Executive Changes - Marketscreener.com

Eagle Pharmaceuticals to Delist from Nasdaq - Investing.com India

Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration - The Manila Times

Eagle Pharmaceuticals to Complete Nasdaq Delisting After Trading Suspension | EGRX Stock News - StockTitan

Eagle Pharmaceuticals (NASDAQ:EGRX) Earns Hold Rating from Analysts at StockNews.com - Defense World

Citigroup Inc's Strategic Reduction in Eagle Pharmaceuticals Inc Shares - GuruFocus.com

Creative Planning Makes New $59,000 Investment in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World

Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial OfficerWOODCLIFF LAKE, N.J. — November 12, 2024 — Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) recently announced the appointment of Christopher Krawtschuk as the Chief - Defense World

Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer - The Manila Times

Eagle Pharmaceuticals, Inc. Announces Chief Financial Officer Changes - Marketscreener.com

Some Major Key Players In The Heparin-Induced Thrombocytopenia (HIT) Treatment Market: - InsightAce Analytic

Nantahala Capital Management Reduces Stake in Eagle Pharmaceuticals - GuruFocus.com

Eagle Pharmaceuticals to Develop Dantrolene Sodium for Potential Treatment of Alzheimer’S Disease in Collaboration with University of Pennsylvania - Marketscreener.com

Eagle Pharmaceuticals Adopts Stockholder Rights Plan to Protect Shareholders’ Interests - Defense World

Union Square Park Capital Management, LLC Increases Stake in Eagle Pharmaceuticals Inc - GuruFocus.com

Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan - The Manila Times

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle - GlobeNewswire

Pemetrexed Market Is Booming Worldwide 2024-2031 | Stada - openPR

Snowflake, Eagle Pharmaceuticals, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - ForexTV.com

Snowflake, Eagle Pharmaceuticals, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire Inc.

Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by Analysts at StockNews.com - Defense World

Global Antiemetics Drugs Market to Exhibit Growth at a CAGR of ~6% by 2030 | DelveInsight - GlobeNewswire

EGRXに似た銘柄